Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Nov 7, 2008; 14(41): 6401-6407
Published online Nov 7, 2008. doi: 10.3748/wjg.14.6401
Published online Nov 7, 2008. doi: 10.3748/wjg.14.6401
ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer
Zhao-Hui Huang, Dong Hua, Li-Hua Li, Yong Mao, Zhi-Hui Liu, Ming-Xu Song, Xi-Ke Zhou, Wuxi Oncology Institute, the Fourth Affiliated Hospital of Suzhou University, Wuxi 214062, Jiangsu Province, China
Zhao-Hui Huang, Xiang Du, Department of Pathology, Cancer Hospital, Fudan University, Shanghai 200032, China
Author contributions: Huang ZH and Hua D was responsible for the study design, data extraction and statistics and Du X for the academic instructions; and Li LH, Mao Y, Liu ZH, Song MX and Zhou XK performed the research.
Supported by A Grant From Scientific and Technologic Bureau of Wuxi, CLZ00612
Correspondence to: Dong Hua, Wuxi Oncology Institute, the Fourth Affiliated Hospital of Suzhou University, 200 Huihe Road, Wuxi, 214062, Jiangsu Province, China. hud21cn@medmail.com.cn
Telephone: +86-510-88683506 Fax: +86-510-88683507
Received: July 6, 2008
Revised: September 19, 2008
Accepted: September 26, 2008
Published online: November 7, 2008
Revised: September 19, 2008
Accepted: September 26, 2008
Published online: November 7, 2008
Core Tip